









Markets
/
Stocks
/
nasdaq-kmts
/

Kestra Medical Technologies Ltd

KMTS

19.460USD

-0.220-1.12%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

963.93MMarket Cap

LossP/E TTM



Kestra Medical Technologies Ltd

19.460

-0.220-1.12%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Kestra Medical Technologies Ltd

Currency: USD Updated: 2026-03-27

Key Insights

Kestra Medical Technologies Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 40 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.71.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Kestra Medical Technologies Ltd's Score

Industry at a Glance

Industry Ranking

40 / 208

Overall Ranking

130 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Kestra Medical Technologies Ltd Highlights

StrengthsRisks

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Growing

The company is in a growing phase, with the latest annual income totaling USD 59.81M.

Overvalued

The company’s latest PE is -7.05, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 50.44M shares, increasing 1.88% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.27M shares of this stock.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

28.714

Target Price

+45.91%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Kestra Medical Technologies Ltd is 7.94, ranking 52 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high.

Score

Industry at a Glance

Previous score

7.94

Change



Financials

8.01

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.33

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.12

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.24

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Kestra Medical Technologies Ltd's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Kestra Medical Technologies Ltd is 7.29, ranking 96 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -7.05, which is -21.12% below the recent high of -5.56 and -52.54% above the recent low of -10.75.

Score

Industry at a Glance

Previous score

7.29

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 40/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Kestra Medical Technologies Ltd is 8.86, ranking 13 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 28.00, with a high of 32.00 and a low of 22.00.

Score

Industry at a Glance

Previous score

8.86

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

28.714

Target Price

+45.91%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Kestra Medical Technologies Ltd

KMTS

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Kestra Medical Technologies Ltd is 6.88, ranking 52 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 23.55 and the support level at 16.52, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.95

Change

-0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.084

Neutral

RSI(14)

38.014

Neutral

STOCH(KDJ)(9,3,3)

43.568

Neutral

ATR(14)

1.826

High Vlolatility

CCI(14)

-68.102

Neutral

Williams %R

69.625

Sell

TRIX(12,20)

-0.989

Sell

StochRSI(14)

21.798

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

20.002

Sell

MA10

19.865

Sell

MA20

20.966

Sell

MA50

23.592

Sell

MA100

24.697

Sell

MA200

22.068

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Kestra Medical Technologies Ltd is 7.00, ranking 81 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 86.44%, representing a quarter-over-quarter decrease of 8.24%. The largest institutional shareholder is PRFDX, holding a total of 4.34M shares, representing 7.43% of shares outstanding, with 349.35% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Bain Capital Private Equity, LP

27.02M

Fidelity Management & Research Company LLC

4.35M

+53.18%

T. Rowe Price Associates, Inc.

Star Investors

1.82M

+83.35%

Endeavour Medtech Growth II LP

2.65M

Ally Bridge Group (HK) Limited

2.28M

Brown Advisory

1.26M

+117.12%

AllianceBernstein L.P.

1.49M

+13.71%

Omega Fund Management, LLC

1.65M

Eventide Asset Management, LLC

1.20M

+13.56%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Kestra Medical Technologies Ltd is 4.68, ranking 99 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.